Srivatsan Raghavan MD

Physician

450 Brookline AveBoston, MA 02215
Phone+1 617-632-3000

Dr. Raghavan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Raghavan's full profile Already have an account?

Education & Training

Johns Hopkins University School of MedicineClass of 2010

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 2013 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

A dependency map enhanced with next-generation 3D cancer models.
James V Neiswender, Samuel Maffa, Lisa Brenan, Dina ElHarouni, Yejie Yun
Nature. 2026-08-05
Evaluating the role of pretraining dataset size and diversity on single-cell foundation model performance.
Alan DenAdel, Madeline Hughes, Akshaya Thoutam, Anay Gupta, Andrew W Navia
Nature Methods. 2026-07-01
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.
Kimberly J Perez, Andressa Dias Costa, Alexander Jordan, Thomas B Karasic, Dalia Elganainy
Nature Cancer. 2026-06-01